# Commission Implementing Regulation (EU) 2018/1967 of 12 December 2018 amending Regulation (EU) No 37/2010 to classify the substance paromomycin as regards its maximum residue limit (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘paromomycin’ is replaced by the following:
Pharmacologically active Substance
Marker residue
Animal Species
MRL
Target Tissues
Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)
Therapeutic Classification
‘Paromomycin
Paromomycin
All food producing species
500 μg/kg
Muscle
For fin fish the muscle MRL relates to ‘muscle and skin in natural proportions’.
MRLs for liver and kidney do not apply to fin fish.
Not for use in animals from which milk is produced for human consumption.
Anti-infectious agents/Antibiotics’
1 500 μg/kg
Liver
1 500 μg/kg
Kidney
200 μg/kg
Eggs

---
Source: https://www.legislation.gov.uk/eur/2018/1967/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2018-1967/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.